Supplementary Figure 3: (A) MS/MS of GSNO standard. (B) MS/MS of total lysate of ARPE-19 cells

Oct 04, 2014

10 likes | 100 Views

Supplementary Figure 3: (A) MS/MS of GSNO standard. (B) MS/MS of total lysate of ARPE-19 cells exposed to normal glucose conditions.

Share Presentation

Embed Code

Link

exposed
gsno standard
total lysate
ms ms
normal glucose conditions
supplementary figure 3

chase

Download Presentation

Supplementary Figure 3: (A) MS/MS of GSNO standard. (B) MS/MS of total lysate of ARPE-19 cells

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Supplementary Figure 3: (A) MS/MS of GSNO standard. (B) MS/MS of total lysate of ARPE-19 cells exposed to normal glucose conditions.

Supplementary Figure 3

Supplementary Figure 3. A. B. Dry weight of grain in a panicle (g/panicle) .

99 views • 1 slides

Supplementary Figure 1

Supplementary Figure 1 Examples of fluorescence images of SFs (A, D), nesprin 1 (B, E), and their merged images (C, F) on the apical and basal sides of SMCs , respectively, to confirm the distribution of nesprin 1, Bar = 10 µm. J. K. P < 0.05. P < 0.05. Frequency of cells

183 views • 4 slides

Supplementary Figure 1

**. Hs578T Cells. Supplementary Figure 1.

82 views • 1 slides

Supplementary Figure S3

Supplementary Figure S3. A. B. HCT116 Cells. SW480 Cells. Cell Size (µm). Cell Size (µm). HMGA1 Knock-down. Control. Control. HMGA1 Knock-down. 100 µm. 100 µm. 100 µm. 100 µm.

143 views • 2 slides

Supplementary Figure 2

Supplementary Figure 2. Supplementary Figure 2 . qRT -PCR-based analysis of LPA and LPC receptor expression in ARMs and ERMS cells lines. Panel A - LPAR1, LPAR2, and LPAR3 receptors. Panel B - G2A and GPR4 receptors. Combined data from two independent experiments are shown. A. B.

145 views • 1 slides

Supplementary figure S1

A. Supplementary figure S1. B. C. D. Figure S1. EGF in combination with LY294002 induces survival and NE differentiation of LNCaP cells.

154 views • 5 slides

Supplementary Figure 1

Article title: PI3K independent activation of mTORC1 as a target in lapatinib-resistant ERBB2+ breast cancer cells Journal: Breast Cancer Research and Treatment

153 views • 3 slides

Supplementary Figure 3

Supplementary Figure 3. Telomeric aUPD. A. Total aUPD. B. MRC. MRC. MRC. MRC. MRC. GIST. GIST. GIST. GIST. GIST. EWS. EWS. EWS. EWS. EWS. aRMS. aRMS. aRMS. aRMS. aRMS. Leiomyosarcoma. Leiomyosarcoma. Leiomyosarcoma. Leiomyosarcoma. Leiomyosarcoma. D. C.

127 views • 1 slides

Supplementary figure 2

Supplementary figure 2 PCA analysis of all the different cell lines used in the microarray experiments revealing three distinct sub groups ; translocation positive RMS cells (RMS, RMZ, RH3, RH40, RH41), translocation negative RMS cells (RD & RH18)and myoblasts (MYO & BIO).

148 views • 1 slides

Supplementary Figure S7

A. MIM-R-GFP. 100. 80. 60. 40. Lung metastasis (14 days). 20. MIM-R-ILEI. 0. MIM-R -GFP. MIM-R -GFP -dnP. MIM-R -ILEI. MIM-R -ILEI -dnP. >100 cells. 50-100 cells. < 50 cells. Supplementary Figure S7. C Lahsnig et al. B. Metastases of different sizes (percent of total).

96 views • 1 slides

Supplementary figure 3

1. 2. 3. 4. 5. 6. M. M. 1. 2. Probe: Unc5b. 7 kb. 28 s RNA. Supplementary figure 3. a. Specificity of the Unc5b splicing morpholino .

95 views • 1 slides

Supplementary figure 1

Supplementary figure 1. Viable. Viable. Apoptotic. Apoptotic. Necrotic. Necrotic. 120. SKOV-3. 100. 80. 60. % total number of cells. 40. 20. 0. 0 hr. 24 hr. 48 hr. 72 hr. 96 hr. - 22 kDa. WB:. - 15 kDa. α Bid α G3PDH. - 37 kDa. Caov-4. SKOV-3. A. 120. Caov-4. 100.

94 views • 1 slides

Supplementary Figure 3

Ctl sip300. p300. E2F1. Actin. Cisp (24h). Supplementary Figure 3. A. B. 25. NT. Cisp (24h). 20. Apoptosis (%). 15. 10. 5. 0. Ctl. sip300. Neutralization of p300 prevents E2F1 accumulation and apoptosis in response to cisplatin.

124 views • 1 slides

SUPPLEMENTARY FIGURE 1

SUPPLEMENTARY FIGURE 1. A. Remove. Full length ErbB2. p185. p185. p95. p95. p95ErbB2. Whole. CEER. Enriched. Lysate. Lysate. B. pLXSN vector. p185 ERBB2. p110 ERBB2. p95m ERBB2.

119 views • 1 slides

Supplementary Data Figure 1

A. B. Supplementary Data Figure 1 A, Binding of Alexa 546-CRP ( red ) to COS-7 cells expressing LOX-1, SR-A, CD36, SR-BI, and dectin-1. b -galactosidase (lacZ) was used as a negative control. The nuclei of the cells were counterstained with DAPI( blue ).

144 views • 1 slides

Supplementary Figure 6

Supplementary Figure 6. B. A. HSC/MFs. MSC. a. a. Wound healing assay. Wound healing assay. **. **. **. **. #. #. #. cells invading the artificial wound. cells invading the artificial wound. #. ##. ##. ##. ##.

117 views • 1 slides

Ruhanen et al., Supplementary Figure 3

Mt-1 (R2). Mt-2 (R2). dsRNA:. Sc. Sc. LIII. LIII. DNA ligase III. HSP 60. Ruhanen et al., Supplementary Figure 2. A. Control. r 0 cells. Gel image of double-stranded DNA arc under UV illuminator. B. Control. r 0 cells. Southern hybridisation.

116 views • 1 slides

Figure S3

H1435. Vehicle. HGF. EGF. pMet. IP: c-Met. c-Met. c-Met. b -Actin. Figure S3. A549. Vehicle. HGF. EGF. pMet. IP: c-Met. c-Met. 1 2.8 9.2. 1 2.1 7.5. c-Met. Total Lysate. Total Lysate. b -Actin. 1 1.3 1.5. 1 1.1 1.8.

74 views • 1 slides

Supplementary Figure 5

Supplementary Figure 5. A. B. MITOCHONDRIA. TOTAL. WT. S46A. WT. S46A. p53. RITA. –. +. +. –. WB: p53. % of apoptotic cells. α-amanitin. –. +. –. +. WB: VDAC. WB: HIPK2. WB: PCNA. WB: p53pS46. NT. RITA. WB: p53. WB: Actin. C. D. pLPC. Pin1-HA. MITOCHONDRIA. TOTAL.

119 views • 1 slides

Supplementary Figure 2

Supplementary Figure 2. PDPN + cells. A. 90.8%. CAF 4. 37.6%. PDPN - cells. 0.44%. low. PDPN. high. B.

120 views • 1 slides

Supplementary Figure 1

Supplementary Figure 1. Expansion of MSCs in 20% oxygen vs 5% oxygen. Supplementary Figure 2. Expansion of Kaneka-filtered cells in Flasks (P4) and the Quantum (P2). Supplementary Figure 3. Adipogenesis. Osteogenesis. Chondrogenesis.

264 views • 8 slides

Supplementary Figure 3

Supplementary Figure 3. PELP1 Tg. Con. A. Phos MAPK. Con. PELP1 Tg. B. Phos AKT. Figure S3. Representative IHC images showing the status of phos -MAPK ( A )and phos -AKT ( B )in the mammary glands of 6-month-old control and MMTV-rtTA-TetO-PELP1 bitransgenic mice.

224 views • 1 slides

More Related